Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Elon Musk will settle the feds’ Twitter lawsuit with pocket change

May 4, 2026

Ontario lottery agency to limit winner names in releases, citing privacy concerns

May 4, 2026

Ballad Health invests $15 million to expand robotic-assisted surgery, earns national accreditation for quality and surgical excellence

May 4, 2026

Sault Ste. Marie Municipal Airport (Sanderson Field) Partners with Air Charter Advisors to Elevate Private Aviation Access in Eastern Upper Peninsula

May 4, 2026

Scorebuddy Launches QA & CX Intelligence Quarterly Pulse Report, Revealing Gap Between AI Strategy and Frontline Reality

May 4, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Mifepristone and Misoprostol are Not “Controlled Dangerous Substances”: The American College of Medical Toxicology Issues Position Statement
Press Release

Mifepristone and Misoprostol are Not “Controlled Dangerous Substances”: The American College of Medical Toxicology Issues Position Statement

By News RoomSeptember 30, 20242 Mins Read
Mifepristone and Misoprostol are Not “Controlled Dangerous Substances”: The American College of Medical Toxicology Issues Position Statement
Share
Facebook Twitter LinkedIn Pinterest Email

Phoenix, AZ, Sept. 30, 2024 (GLOBE NEWSWIRE) — In May of 2024, Louisiana enacted a law classifying mifepristone and misoprostol as Schedule IV controlled dangerous substances, akin to medications that pose risks for addiction and misuse, such as opioids and benzodiazepines. This law makes unauthorized possession or distribution of either of these medications a felony, punishable by hefty fines and prison terms of up to 10 years.

The American College of Medical Toxicology (ACMT), a leading toxicology society, whose members comprise physicians board certified in medical toxicology, and healthcare professionals, including pharmacists, with advanced training in pharmacology, is particularly well-positioned to accurately assess this issue. ACMT has issued a position statement, “Mifepristone and Misoprostol are Not Controlled Dangerous Substances,” which has also been endorsed by the American Academy of Clinical Toxicology (AACT), an organization of scientists and clinicians in research, education, prevention and treatment of diseases caused by drugs.

According to Andrew Stolbach, MD, FACMT, Chair of the ACMT Position Statements Committee, “the position statement released by ACMT asserts that these medications do not meet the criteria for controlled substances, and warns that this classification is not consistent with decades of scientific evidence regarding the safety, misuse, and addiction potential of these medications.” Additionally the statement details how this action may lead to harm, diminished capacity for quality patient care, and sets a troubling precedent for pharmaceutical regulation.

The statement further covers why and how the new classification may have far-reaching unintended negative effects. Unlike traditional Schedule IV substances, illegal possession of mifepristone or misoprostol typically does not involve misuse for euphoria. The requirement for special storage and documentation could hinder pharmacy operations, impacting the availability of these medications during emergencies, such as postpartum hemorrhage. Furthermore, these harsh penalties could drive individuals to seek more dangerous alternatives or avoid necessary medical care due to fear of legal repercussions.

Read the position statement in full here.

The American College of Medical Toxicology (ACMT) is a professional, nonprofit association of physicians board certification in medical toxicology and other professionals with expertise in this area. ACMT members specialize in the prevention, evaluation, treatment, and monitoring of injury and illness from exposures to drugs and chemicals, as well as biological and radiological agents, and work in clinical, academic, governmental, and public health settings, and provide poison control center leadership.

  • Mifepristone and Misoprostol are Not “Controlled Dangerous Substances”: The American College of Medical Toxicology Issues Position Statement

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Ballad Health invests $15 million to expand robotic-assisted surgery, earns national accreditation for quality and surgical excellence

Sault Ste. Marie Municipal Airport (Sanderson Field) Partners with Air Charter Advisors to Elevate Private Aviation Access in Eastern Upper Peninsula

Scorebuddy Launches QA & CX Intelligence Quarterly Pulse Report, Revealing Gap Between AI Strategy and Frontline Reality

FOXVISITS LTD Repositions as an AI-First Digital Marketing Agency for International Service Businesses

CZR Exchange Launches Major Mobile App Upgrade with Advanced Portfolio Analytics and Enhanced User Experience

Canon and Local Organizations Celebrate Earth Day 2026 with Community Recycling Drives at Melville Headquarters

Air Sense Environmental Reports Surge in Radon Mitigation in St. Louis as Spring Market Peaks

MSCcasino.com Announces Sponsorship of Professional Snooker Player Aaron Hill

Genyro Announces New Paper Demonstrating How Sidewinder Technology Democratizes DNA Construction at Scale and Facilitates AI-Driven Protein Design

Editors Picks

Ontario lottery agency to limit winner names in releases, citing privacy concerns

May 4, 2026

Ballad Health invests $15 million to expand robotic-assisted surgery, earns national accreditation for quality and surgical excellence

May 4, 2026

Sault Ste. Marie Municipal Airport (Sanderson Field) Partners with Air Charter Advisors to Elevate Private Aviation Access in Eastern Upper Peninsula

May 4, 2026

Scorebuddy Launches QA & CX Intelligence Quarterly Pulse Report, Revealing Gap Between AI Strategy and Frontline Reality

May 4, 2026

Latest News

FOXVISITS LTD Repositions as an AI-First Digital Marketing Agency for International Service Businesses

May 4, 2026

CZR Exchange Launches Major Mobile App Upgrade with Advanced Portfolio Analytics and Enhanced User Experience

May 4, 2026

Flying or driving? Fuel shock means summer travel will happen ‘differently’

May 4, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version